Insider Transactions in Q3 2022 at Abeona Therapeutics Inc. (ABEO)
Insider Transaction List (Q3 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 28
2022
|
Brendan M. O'Malley SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
72,750
+47.48%
|
-
|
Sep 28
2022
|
Vishwas Seshadri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
155,200
+48.33%
|
-
|
Sep 28
2022
|
Joseph Walter Vazzano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,750
+43.96%
|
-
|
Sep 26
2022
|
Donald A. Wuchterl Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+39.63%
|
-
|
Sep 26
2022
|
Mark Alvino Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+42.12%
|
-
|
Sep 26
2022
|
Paul Elliot Mann Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+44.21%
|
-
|
Sep 26
2022
|
Todd Wider Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+44.21%
|
-
|
Sep 26
2022
|
Michael Amoroso Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+18.84%
|
-
|
Sep 26
2022
|
Christine Berni Silverstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+27.39%
|
-
|
Sep 26
2022
|
Leila Alland Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+39.63%
|
-
|
Sep 26
2022
|
Faith L. Charles Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+39.63%
|
-
|
Sep 21
2022
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
479
-5.02%
|
$1,437
$3.72 P/Share
|
Jul 21
2022
|
Joseph Walter Vazzano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+37.5%
|
-
|